Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1161932-04-2

Post Buying Request

1161932-04-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1-Piperidinecarboxylic acid, 4-amino-3-hydroxy-, 1,1-dimethylethyl ester, (3S,4S)-/ LIDE PHARMA- Factory supply / Best price

    Cas No: 1161932-04-2

  • No Data

  • 1 Kilogram

  • 1000 Kilogram/Day

  • LIDE PHARMACEUTICALS LIMITED
  • Contact Supplier

1161932-04-2 Usage

General Description

The chemical compound (3S,4S)-4-aMino-3-hydroxy-piperidine-1-carboxylic acid tert-butyl ester, also known as L-hydroxyproline tert-butyl ester, is a derivative of the amino acid proline. It is a white crystalline solid with a molecular formula of C11H21NO3 and a molecular weight of 215.29 g/mol. (3S,4S)-4-aMino-3-hydroxy-piperidine-1-carboxylic acid tert-butyl ester is commonly used in the synthesis of peptides and pharmaceutical compounds, particularly in the production of collagen and other proteins. It is also used as a chiral building block in organic synthesis, as well as a reagent in the production of enantiomerically pure compounds. Additionally, L-hydroxyproline tert-butyl ester has been studied for its potential applications in drug development and as a biomarker for certain medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 1161932-04-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,1,9,3 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1161932-04:
(9*1)+(8*1)+(7*6)+(6*1)+(5*9)+(4*3)+(3*2)+(2*0)+(1*4)=132
132 % 10 = 2
So 1161932-04-2 is a valid CAS Registry Number.

1161932-04-2Relevant articles and documents

MINERALOCORTICOID RECEPTOR ANTAGONISTS AND METHODS OF USE

-

Page/Page column 28, (2009/07/10)

The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1161932-04-2